Page 29 - TD-2-3
P. 29

Tumor Discovery                                         Targeted drug delivery systems for the treatment of tumors



               uptake  by  Japanese  flounder  (Paralichthys olivaceus)  red   32: 2106–2116.
               blood cells: Size dependence and pathway specificity. Tissue
               Cell, 61: 79–88.                                   https://doi.org/10.1016/j.biomaterials.2010.11.056
                                                               22.  Townsend AR, Chong LC, Karapetis C, et al., 2016, Selective
               https://doi.org/10.1016/j.tice.2019.09.002
                                                                  internal  radiation therapy for  liver metastases  from
            11.  Kutova OM, Guryev EL, Sokolova EA, et al., 2019, Targeted   colorectal cancer. Cancer Treat Rev, 50: 148–154.
               delivery to tumors: Multidirectional strategies to improve
               treatment efficiency. Cancers (Basel), 11: 68.      https://doi.org/10.1016/j.ctrv.2016.09.007
                                                               23.  Sangi S, Sree HN, Bawadekji A, et al., 2018, Chemotherapeutic
               https://doi.org/10.3390/cancers11010068
                                                                  drug targeting to lungs by way of microspheres after
            12.  Gu YT, Xue YX, Wang YF, et al., 2012, Role of ROS/RhoA/  intravenous administration.  Drug Des Devel Ther, 12: 
               PI3K/PKB signaling in NS1619-mediated blood-tumor   3051–3060.
               barrier permeability increase. J Mol Neurosci, 48: 302–312.
                                                                  https://doi.org/10.2147/DDDT.S173485
               https://doi.org/10.1007/s12031-012-9789-2
                                                               24.  Fan R, Li X, Deng J,  et al., 2016. Dual drug loaded
            13.  Deryugina EI, 2016, Chorioallantoic membrane microtumor   biodegradable nanofibrous microspheres for improving
               model to study the mechanisms of tumor angiogenesis,   anti-colon cancer activity. Sci Rep, 6: 28373.
               vascular permeability, and tumor cell intravasation. Methods
               Mol Biol, 1430: 283–298.                        25.  Shell JR, Gendron LN, LaRochelle EP, et al., 2019, Tumor
                                                                  Targeting Cetuximab Conjugated Europium Microspheres
               https://doi.org/10.1007/978-1-4939-3628-1_19       for Cherenkov Excited Luminescence Scanned Imaging
            14.  Uhlen M, Zhang C, Lee S, et al., 2017, A pathology atlas of   (Conference Presentation). In: Proceedings of Molecular-
               the human cancer transcriptome. Science, 357: eaan2507.   Guided Surgery: Molecules, Devices, and Applications. Vol.
                                                                  10862. p. 1086217.
               https://doi.org/10.1126/science.aan2507
                                                                  https://doi.org/10.1117/12.2515383
            15.  Naik H, Sonju  JJ, Singh S,  et al., 2021, Lipidated
               peptidomimetic ligand-functionalized HER2 targeted   26.  Shukla T, Upmanyu N, Agrawal M, et al., 2018, Biomedical
               liposome as nano-carrier designed for doxorubicin delivery   applications of microemulsion through dermal and
               in cancer therapy. Pharmaceuticals (Basel), 14: 221.   transdermal route. Biomed Pharmacother, 108: 1477–1494.
               https://doi.org/10.3390/ph14030221                 https://doi.org/10.1016/j.biopha.2018.10.021
            16.  Dvorak HF, 2015, Tumor stroma, tumor blood vessels, and   27.  Naves LB, Almeida L, Marques MJ, et al., 2017, Emulsions
               antiangiogenesis therapy. Cancer J, 21: 237–243.   stabilization for topical application. Biomater Med Appl, 1: 1.
               https://doi.org/10.1097/PPO.0000000000000124    28.  Murthy  R,  Habbul A,  2006,  Trans-arterial  hepatic
                                                                  radioembolisation of yttrium-90  microspheres.  Biomed
            17.  Goel S, Chen F, Hong H, et al., 2014, VEGF₁₂₁-conjugated
               mesoporous silica nanoparticle: A  tumor targeted drug   Imag Interven J, 2: e43.
               delivery system. ACS Appl Mater Interfaces, 6: 21677–21685.      https://doi.org/10.2349/biij.2.3.e43
               https://doi.org/10.1021/am506849p               29.  Yehia R, Hathout RM, Attia DA,  et al., 2017, Anti-tumor
            18.  Prager GW, Poettler M, Unseld M, et al., 2012, Angiogenesis   efficacy of an integrated methyl dihydrojasmonate
               in cancer: Anti-VEGF escape mechanisms.  Transl  Lung   transdermal microemulsion system targeting breast cancer
               Cancer Res, 1: 14–25.                              cells: In vitro and in vivo studies. Colloids Surf B Biointerfaces,
                                                                  1: 512–521.
               https://doi.org/10.3978/j.issn.2218-6751.2011.11.02
                                                                  https://doi.org/10.1016/j.colsurfb.2017.04.031
            19.  Ma X, Xiong Y, Lee LTO, 2018, Application of nanoparticles
               for targeting G protein-coupled receptors.  Int J Mol Sci,   30.  Enriquez GG, Rizvi SA, D’Souza MJ,  et al., 2013,
               19: 2006.                                          Formulation and evaluation of drug-loaded targeted
                                                                  magnetic microspheres for cancer therapy. Int J Nanomed,
               https://doi.org/10.3390/ijms19072006               8: 1393–1402.
            20.  Huang  B,  Abraham  WD,  Zheng  Y,  et al.,  2015,  Active      https://doi.org/10.2147/IJN.S43479
               targeting of chemotherapy to disseminated tumors using
               nanoparticle-carrying T cells. Sci Transl Med, 7: 291ra94.   31.  Cordeiro  Pedrosa  LR,  van  Tellingen  O,  Soullié  T,
                                                                  et al., 2015, Plasma membrane targeting by short chain
               https://doi.org/10.1126/scitranslmed.aaa5447
                                                                  sphingolipids inserted in liposomes improves anti-
            21.  Roger M, Clavreul A, Venier-Julienne MC,  et al., 2011,   tumor activity of mitoxantrone in an orthotopic breast
               The potential of combinations of drug-loaded nanoparticle   carcinoma xenograft model.  Eur J Pharm Biopharm,
               systems and adult stem cells for glioma therapy. Biomaterials,   94: 207–219.


            Volume 2 Issue 3 (2023)                         23                         https://doi.org/10.36922/td.1356
   24   25   26   27   28   29   30   31   32   33   34